country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-N9488

Copy Link Print Information

Girinimbine

(Synonyms: Girinimbin)

Customer Review

Based on 1 Customer Validation

Girinimbine (Girinimbin) is a carbazole alkaloid with a variety of biological effects. Girinimbine can induce apoptosis, and has antitrypanosomal, antiplatelet activity, antibacterial activity, anti-inflammatory, antioxidant and antitumor activities.

For research use only. We do not sell to patients.

Purity: 99.23%
CAS No.: 23095-44-5
Formula: C₁₈H₁₇NO
Molecular Weight:263.33

Storage:

4°C, sealed storage, away from moisture and light

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

Girinimbine Chemical Structure

CAS No.: 23095-44-5

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

All Parasite Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
A2780	IC₅₀	>50 μM Compound: Girinimbine	Anticancer activity against human A2780 cells by MTT assay Anticancer activity against human A2780 cells by MTT assay	[PMID: 33316408]
A-431	IC₅₀	>50 μM Compound: Girinimbine	Anticancer activity against human A431 cells by MTT assay Anticancer activity against human A431 cells by MTT assay	[PMID: 33316408]
Bel-7402	IC₅₀	>50 μM Compound: Girinimbine	Anticancer activity against human H7402 cells by MTT assay Anticancer activity against human H7402 cells by MTT assay	[PMID: 33316408]
BGC-823	IC₅₀	>50 μM Compound: Girinimbine	Anticancer activity against human BGC-823 cells by MTT assay Anticancer activity against human BGC-823 cells by MTT assay	[PMID: 33316408]
HCT-8	IC₅₀	34.69 μM Compound: Girinimbine	Anticancer activity against human HCT-8 cells by MTT assay Anticancer activity against human HCT-8 cells by MTT assay	[PMID: 33316408]
HeLa	IC₅₀	>50 μM Compound: Girinimbine	Anticancer activity against human HeLa cells by MTT assay Anticancer activity against human HeLa cells by MTT assay	[PMID: 33316408]
HepG2	IC₅₀	>160 μM Compound: 7	Growth inhibition of human HepG2 cells after 48 hrs by WST-8 based CCK8 assay Growth inhibition of human HepG2 cells after 48 hrs by WST-8 based CCK8 assay	[PMID: 22093759]
KB	IC₅₀	263.1 μM Compound: 7	Cytotoxicity against human KB cells by resazurin reduction assay Cytotoxicity against human KB cells by resazurin reduction assay	[PMID: 22482432]
KB	IC₅₀	7.02 μM Compound: 5	Cytotoxicity against human KB cells by resazurin microplate assay Cytotoxicity against human KB cells by resazurin microplate assay	[PMID: 21302964]
KETR3	IC₅₀	>50 μM Compound: Girinimbine	Anticancer activity against human KETR3 cells by MTT assay Anticancer activity against human KETR3 cells by MTT assay	[PMID: 33316408]
MCF7	IC₅₀	28.8 μM Compound: 7	Cytotoxicity against human MCF7 cells by resazurin reduction assay Cytotoxicity against human MCF7 cells by resazurin reduction assay	[PMID: 22482432]
MCF7	IC₅₀	49.76 μM Compound: Girinimbine	Anticancer activity against human MCF7 cells by MTT assay Anticancer activity against human MCF7 cells by MTT assay	[PMID: 33316408]
NCI-H187	IC₅₀	22.37 μM Compound: 5	Cytotoxicity against human NCI-H187 by resazurin microplate assay Cytotoxicity against human NCI-H187 by resazurin microplate assay	[PMID: 21302964]
NCI-H187	IC₅₀	58.9 μM Compound: 7	Cytotoxicity against human NCI-H187 cells by resazurin reduction assay Cytotoxicity against human NCI-H187 cells by resazurin reduction assay	[PMID: 22482432]
NCI-H460	IC₅₀	27.01 μM Compound: Girinimbine	Anticancer activity against human H460 cells by MTT assay Anticancer activity against human H460 cells by MTT assay	[PMID: 33316408]
SW1990	IC₅₀	>50 μM Compound: Girinimbine	Anticancer activity against human SW1990 cells by MTT assay Anticancer activity against human SW1990 cells by MTT assay	[PMID: 33316408]
Vero	IC₅₀	>200 μM Compound: 5	Cytotoxicity against african green monkey Vero cells by green fluorescent protein microplate assay Cytotoxicity against african green monkey Vero cells by green fluorescent protein microplate assay	[PMID: 21302964]

In Vitro

Girinimbine (1-400 µM; 24-72 h) decreases the viability of HepG2 cells in 24, 48 and 72 h with IC₅₀ values of 61 µM, 56 µM, and 40 µM respectively. Girinimbine (10-100 µM; 24-48 h) increase of LDH leakage in both concentration- and time-dependent manner in HepG2 cells^[1].
Girinimbine (56 µM; 24-48 h) treatment results in DNA fragmentation and elevates levels of caspase-3 in HepG2 cells^[1]. HepG2 cells^[1].
Girinimbine (56 µM; 12-48 h) treatment also displays a time-dependent accumulation of the Sub-G0/G1 peak (hypodiploid) and caused G0/G1-phase arrest^[1].
Girinimbine shows a potent antitrypanosomal activitywith an IC₅₀ value of 10.16 µg/mL^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

HepG2 cells
Concentration:

1 µM, 10 µM, 50 µM, 100 µM, 200 µM
Incubation Time:

24 h, 48 h and 72 h
Result:

Inhibited the proliferation of HepG2 cells in vitro in a dose- and time-dependent manner.

Apoptosis Analysis^[1]

Cell Line:

HepG2 cells
Concentration:

56 µM
Incubation Time:

24 h, 48 h
Result:

Showed typical morphological features of apoptosis.

Cell Cycle Analysis^[1]

Cell Line:

HepG2 cells
Concentration:

56 µM
Incubation Time:

12 h, 24 h, 48 h
Result:

Induced G0/G1-phase arrest in HepG2 cells.

In Vivo

Girinimbine (10-100 mg/kg; orally gavage; once) pretreatment helps limit total leukocyte migration, and reduced pro-inflammatory cytokine (IL-1β, TNF-α) levels in the peritoneal fluid^[2].
In vivo in zebrafish embryos, Girinimbine (20 μg/mL; 24 hours) shows significant distribution of apoptotic cells in embryos^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Male ICR mice (25-35 g) treated with carrageenan^[2]
Dosage:

10 mg/kg, 30 mg/kg, and 100 mg/kg
Administration:

Orally gavage; once
Result:

Helped limit total leukocyte migration, and reduced pro-inflammatory cytokine levels in the peritoneal fluid.

Chemical Information

CAS No. 23095-44-5
Appearance Solid
Molecular Weight 263.33
Formula C₁₈H₁₇NO
Color Off-white to light yellow
SMILES

CC(OC1=C(C)C=C23)(C)C=CC1=C3NC4=C2C=CC=C4
Synonyms

Girinimbin
Structure Classification
- Alkaloids
- Indole Alkaloids
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

4°C, sealed storage, away from moisture and light

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (277 KB)
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Suvitha Syam, et al. The growth suppressing effects of girinimbine on HepG2 involve induction of apoptosis and cell cycle arrest. Molecules. 2011 Aug 23;16(8):7155-70. [Content Brief]

[2]. Venoos Iman, et al. Anticancer and anti-inflammatory activities of girinimbine isolated from Murraya koenigii. Drug Des Devel Ther. 2016 Dec 28;11:103-121. [Content Brief]

[3]. H O Dyary, et al. Antitrypanosomal and cytotoxic activities of botanical extracts from Murraya koenigii (L.) and Alpinia mutica Roxb. Trop Biomed. 2019 Mar 1;36(1):94-102. [Content Brief]

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

100 mg

Get Quote In-stock

Amount: USD 0.00

Biological Activity
- Description
- In Vitro
- In Vivo
Chemical Information
Purity & Documentation
References

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

Girinimbine

All Parasite Isoforms

Biological Activity

Chemical Information

Purity & Documentation

References

Calculators

Help & FAQs

Girinimbine Related Classifications

HY-N9488 Related Classifications